{"result": {"id": "6b96cd79-3865-48ce-bba9-02f62ca135a8", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>哈尔滨医科大学附属第一医院风湿免疫科<|>ORGANIZATION<|>A department within Harbin Medical University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>张卓莉<|>PERSON<|>A rheumatology and immunology specialist at Peking University First Hospital>  \n##  \n(\"entity\"<|>北京大学第一医院风湿免疫科<|>ORGANIZATION<|>A department within Peking University First Hospital specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>赵东宝<|>PERSON<|>A rheumatology and immunology specialist at the First Affiliated Hospital of Naval Medical University>  \n##  \n(\"entity\"<|>海军军医大学第一附属医院风湿免疫科<|>ORGANIZATION<|>A department within the First Affiliated Hospital of Naval Medical University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>赵久良<|>PERSON<|>A rheumatology and immunology specialist at Peking Union Medical College Hospital>  \n##  \n(\"entity\"<|>中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>ORGANIZATION<|>A department within Peking Union Medical College Hospital specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>赵丽珂<|>PERSON<|>A rheumatology and immunology specialist at Beijing Hospital>  \n##  \n(\"entity\"<|>北京医院风湿免疫科<|>ORGANIZATION<|>A department within Beijing Hospital specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>赵令<|>PERSON<|>A rheumatology and immunology specialist at the First Hospital of Jilin University>  \n##  \n(\"entity\"<|>吉林大学第一医院风湿免疫科<|>ORGANIZATION<|>A department within the First Hospital of Jilin University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>赵岩<|>PERSON<|>A rheumatology and immunology specialist at Peking Union Medical College Hospital>  \n##  \n(\"entity\"<|>赵彦萍<|>PERSON<|>A rheumatology and immunology specialist at Harbin Medical University First Affiliated Hospital>  \n##  \n(\"entity\"<|>赵毅<|>PERSON<|>A rheumatology and immunology specialist at West China Hospital of Sichuan University>  \n##  \n(\"entity\"<|>四川大学华西医院风湿免疫科<|>ORGANIZATION<|>A department within West China Hospital of Sichuan University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>郑朝晖<|>PERSON<|>A clinical immunology specialist at Xijing Hospital of Air Force Medical University>  \n##  \n(\"entity\"<|>空军军医大学西京医院临床免疫科<|>ORGANIZATION<|>A department within Xijing Hospital of Air Force Medical University specializing in clinical immunology>  \n##  \n(\"entity\"<|>郑文洁<|>PERSON<|>A rheumatology and immunology specialist at Peking Union Medical College Hospital>  \n##  \n(\"entity\"<|>周京国<|>PERSON<|>A rheumatology and immunology specialist at the First Affiliated Hospital of Chengdu Medical College>  \n##  \n(\"entity\"<|>成都医学院第一附属医院风湿免疫科<|>ORGANIZATION<|>A department within the First Affiliated Hospital of Chengdu Medical College specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>朱小春<|>PERSON<|>A rheumatology and immunology specialist at the First Affiliated Hospital of Wenzhou Medical University>  \n##  \n(\"entity\"<|>温州医科大学附属第一医院风湿免疫科<|>ORGANIZATION<|>A department within the First Affiliated Hospital of Wenzhou Medical University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>朱小霞<|>PERSON<|>A rheumatology and immunology specialist at Huashan Hospital of Fudan University>  \n##  \n(\"entity\"<|>复旦大学附属华山医院风湿免疫科<|>ORGANIZATION<|>A department within Huashan Hospital of Fudan University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>邹和建<|>PERSON<|>A rheumatology and immunology specialist at Huashan Hospital of Fudan University>  \n##  \n(\"entity\"<|>邹庆华<|>PERSON<|>A rheumatology and immunology specialist at the First Affiliated Hospital of Army Medical University>  \n##  \n(\"entity\"<|>陆军军医大学第一附属医院风湿免疫科<|>ORGANIZATION<|>A department within the First Affiliated Hospital of Army Medical University specializing in rheumatology and immunology>  \n##  \n(\"entity\"<|>左晓霞<|>PERSON<|>A rheumatology and immunology specialist at Xiangya Hospital of Central South University>  \n##  \n(\"entity\"<|>中南大学湘雅医院风湿免疫科<|>ORGANIZATION<|>A department within Xiangya Hospital of Central South University specializing in rheumatology and immunology>  \n##  \n(\"relationship\"<|>张卓莉<|>北京大学第一医院风湿免疫科<|>张卓莉 is a specialist at 北京大学第一医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵东宝<|>海军军医大学第一附属医院风湿免疫科<|>赵东宝 is a specialist at 海军军医大学第一附属医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵久良<|>中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>赵久良 is a specialist at 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵丽珂<|>北京医院风湿免疫科<|>赵丽珂 is a specialist at 北京医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵令<|>吉林大学第一医院风湿免疫科<|>赵令 is a specialist at 吉林大学第一医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵岩<|>中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>赵岩 is a specialist at 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵彦萍<|>哈尔滨医科大学附属第一医院风湿免疫科<|>赵彦萍 is a specialist at 哈尔滨医科大学附属第一医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>赵毅<|>四川大学华西医院风湿免疫科<|>赵毅 is a specialist at 四川大学华西医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>郑朝晖<|>空军军医大学西京医院临床免疫科<|>郑朝晖 is a specialist at 空军军医大学西京医院临床免疫科<|>9>  \n##  \n(\"relationship\"<|>郑文洁<|>中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>郑文洁 is a specialist at 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>周京国<|>成都医学院第一附属医院风湿免疫科<|>周京国 is a specialist at 成都医学院第一附属医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>朱小春<|>温州医科大学附属第一医院风湿免疫科<|>朱小春 is a specialist at 温州医科大学附属第一医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>朱小霞<|>复旦大学附属华山医院风湿免疫科<|>朱小霞 is a specialist at 复旦大学附属华山医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>邹和建<|>复旦大学附属华山医院风湿免疫科<|>邹和建 is a specialist at 复旦大学附属华山医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>邹庆华<|>陆军军医大学第一附属医院风湿免疫科<|>邹庆华 is a specialist at 陆军军医大学第一附属医院风湿免疫科<|>9>  \n##  \n(\"relationship\"<|>左晓霞<|>中南大学湘雅医院风湿免疫科<|>左晓霞 is a specialist at 中南大学湘雅医院风湿免疫科<|>9>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165346, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 1945, "prompt_tokens": 2549, "total_tokens": 4494, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 757}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �（哈  尔滨医科大学附属第一医院风湿免疫科）；张卓莉（北京大  学第一医院风湿免疫科）；赵东宝（海军军医大学第一附属  医院风湿免疫科）；赵久良（中国医学科学院 北京协和医学  院 北京协和医院风湿免疫科）；赵丽珂（北京医院风湿免疫  科 国家老年医学中心 中国医学科学院老年医学研究院）； 赵令（吉林大学第一医院风湿免疫科）；赵岩（中国医学科学  院 北京协和医学院 北京协和医院风湿免疫科）；赵彦萍（哈  尔滨医科大学附属第一医院风湿免疫科）；赵毅（四川大学  华西医院风湿免疫科）；郑朝晖（空军军医大学西京医院临  床免疫科）；郑文洁（中国医学科学院 北京协和医学院 北京  协和医院风湿免疫科）；周京国（成都医学院第一附属医院  风湿免疫科）；朱小春（温州医科大学附属第一医院风湿免  疫科）；朱小霞（复旦大学附属华山医院风湿免疫科）；邹和  建（复旦大学附属华山医院风湿免疫科）；邹庆华（陆军军医  大学第一附属医院风湿免疫科）；左晓霞（中南大学湘雅医  院风湿免疫科 湖南省风湿免疫病临床医学研究中心）\n利益冲突  所有作者声明无利益冲突\n\n参  考  文  献\n\n[1]      Zhang  M,  Zhu X, Wu  J,  et al.  Prevalence of hyperuricemia among    chineseadults:    findings    from    two     nationally representative   cross‐sectional  surveys  in   2015‐16  and\n2018 ‐ 19 [J].  Front  Immunol,  2022,  12: 791983. DOI:  10. 3389/fimmu.2021.791983.\n[2]       中华医学会风湿病学分会 . 原发性痛风诊断及治疗指南[J]. 中华风湿病学杂志, 2011, 15 (6): 410‐413. DOI: 10.3760/ cma.j.issn.1007‐7480.2011.06.013.\n[3]       中华医学会风湿病学分会 . 2016 中国痛风诊疗指南[J]. 中 华内科杂志 , 2016, 55 (11): 892‐899. DOI: 10.3760/cma.j. issn.0578‐1426.2016.11.019.\n[4]       Neogi    T,    Jansen    TL,    Dalbeth    N,    et al.     2015    Gout classification      criteria:      an      American       College      of Rheumatology/European    League   Against    Rheumatism collaborative  initiative[J]. Ann  Rheum  Dis,  2015,  74 (10): 1789‐1798. DOI: 10.1136/annrheumdis‐2015‐208237.\n[5]       Richette  P,  Doherty  M,  Pascual  E,  et al.   2016  updated EULAR      evidence‐based     recommendations      for      the\n\n\n\n·  1076   ·                                                              中华内科杂志 2023 年 9 月第 62 卷第 9 期    Chin J Intern Med, September 2023, Vol. 62, No. 9\n\n\nmanagement  of\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_8f2b9df24e66d2602fd44968d0f30f77ed867d42e9df0c57346ff65561b22376_v2"}